CytomX Therapeutics, Inc. Annual Operating Margin in % from 2013 to 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
CytomX Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2013 to 2024.
  • CytomX Therapeutics, Inc. Operating Margin for the quarter ending June 30, 2025 was 30.6 %, a 539% increase year-over-year.
  • CytomX Therapeutics, Inc. annual Operating Margin for 2024 was 18.1 %.
  • CytomX Therapeutics, Inc. annual Operating Margin for 2023 was -6.41 %, a 96.6% increase from 2022.
  • CytomX Therapeutics, Inc. annual Operating Margin for 2022 was -191 %, a 38.7% increase from 2021.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 18.1 +24.5 Jan 1, 2024 Dec 31, 2024
2023 -6.41 +184 +96.6% Jan 1, 2023 Dec 31, 2023
2022 -191 +120 +38.7% Jan 1, 2022 Dec 31, 2022
2021 -311 -193 -164% Jan 1, 2021 Dec 31, 2021
2020 -118 +408 +77.6% Jan 1, 2020 Dec 31, 2020
2019 -526 -395 -302% Jan 1, 2019 Dec 31, 2019
2018 -131 -66.3 -103% Jan 1, 2018 Dec 31, 2018
2017 -64.6 +332 +83.7% Jan 1, 2017 Dec 31, 2017
2016 -396 +34.4 +8% Jan 1, 2016 Dec 31, 2016
2015 -431 +156 +26.6% Jan 1, 2015 Dec 31, 2015
2014 -586 +1.1K +65.2% Jan 1, 2014 Dec 31, 2014
2013 -1.68K Jan 1, 2013 Dec 31, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.